Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEGON LTD.AEG · Entity 3394 | Director | September 24, 2026 | September 28, 2026 |
| DXC Technology CoDXC · Entity 4594 | Director | August 04, 2026 | August 06, 2026 |
| METLIFE INCMET · Entity 488 | Director | April 01, 2025 | April 03, 2025 |
| OCTAVE SPECIALTY GROUP INCAMBC · Entity 6308 | Director | April 03, 2023 | April 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEGON LTD.
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 24,985 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 257 · Balance 24,985 F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards.
DXC Technology Co
Report date August 04, 2026 · Filed August 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 147,301 |
Reported balance
After 2026-08-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-04 · Grant · Acquired 30,900 · Balance 147,301 F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2: Amount reported includes unvested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.
F2: Amount reported includes unvested RSUs.
METLIFE INC
Report date April 01, 2025 · Filed April 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,138 |
Reported balance
After 2025-04-01 transaction · row 1
1 source rowRow 1 · 2025-04-01 · Grant · Acquired 218 · Balance 26,138 F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. F2: The amount reported reflects a prorated portion of the non-management director retainer fees beginning April 1, 2025 and ending May 1, 2025, the effective date of the director's resignation from the Board. |
| Common StockSEC Table I · non-derivative | Indirectby David L. Herzog Trust | 87 |
Reported balance
Holding disclosure · report date 2025-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 87 |
Filing footnotes · ownership attribution and instrument terms
F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2: The amount reported reflects a prorated portion of the non-management director retainer fees beginning April 1, 2025 and ending May 1, 2025, the effective date of the director's resignation from the Board.
OCTAVE SPECIALTY GROUP INC
Report date April 03, 2023 · Filed April 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 93,057 |
Reported balance
After 2023-04-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-04-03 · Grant · Acquired 3,277 · Balance 93,057 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").
F2: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 28, 2026 20:45 UTC | AEGON LTD. AEG · Entity 3394 | GrantCommon Shares | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-044598 · ownership.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,985 F1 · kind: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards. Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 20:45 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 30,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-26-000078 · wk-form4_1786049104.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,301 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 20:30 UTC | AEGON LTD. AEG · Entity 3394 | GrantCommon Shares | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-032522 · ownership.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,728 F1 · kind: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 22:01 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 25,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-25-000083 · wk-form4_1754604061.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,401 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2026 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:28 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 218 | $81.16 | $17,692.88 |
DisclosureSEC source: 0001099219-25-000117 · wk-form4_1743712099.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,138 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. F2 · shares: The amount reported reflects a prorated portion of the non-management director retainer fees beginning April 1, 2025 and ending May 1, 2025, the effective date of the director's resignation from the Board. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:18 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 46 | $78.45 | $3,608.70 |
DisclosureSEC source: 0001099219-25-000088 · wk-form4_1741897086.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,920 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:41 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 535 | $81.78 | $43,752.30 |
DisclosureSEC source: 0001099219-25-000035 · wk-form4_1736199698.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,875 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:33 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 39 | $82.74 | $3,226.86 |
DisclosureSEC source: 0001099219-24-000287 · wk-form4_1734557625.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,340 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000247 · wk-form4_1727986593.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,300 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:32 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 43 | $74.63 | $3,209.09 |
DisclosureSEC source: 0001099219-24-000224 · wk-form4_1726173146.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,765 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 22:20 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 17,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000082 · wk-form4_1723760407.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,701 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:19 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 3,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000067 · wk-form4_1722543531.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,301 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs vested at grant. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 00:43 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 3,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000061 · wk-form4_1719967421.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,903 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:38 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000186 · wk-form4_1718915894.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,722 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:20 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 47 | $69.06 | $3,245.82 |
DisclosureSEC source: 0001099219-24-000158 · wk-form4_1718310007.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,095 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:48 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 4,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000057 · wk-form4_1717534096.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,149 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| April 30, 2024 Filed May 2, 2024 21:27 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 3,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000025 · wk-form4_1714685220.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,540 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:23 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 594 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000126 · wk-form4_1712175785.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,048 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 22:58 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 3,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000019 · wk-form4_1712012325.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,863 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 20:47 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 42 | $71.90 | $3,019.80 |
DisclosureSEC source: 0001099219-24-000088 · wk-form4_1710794851.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,454 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:41 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 3,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000015 · wk-form4_1710535302.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,484 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:49 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 3,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000011 · wk-form4_1706910584.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,029 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:29 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-24-000003 · wk-form4_1704490140.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,742 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:37 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000022 · wk-form4_1704404244.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,412 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:20 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 45 | $66.90 | $3,010.50 |
DisclosureSEC source: 0001099219-23-000296 · wk-form4_1702938034.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,762 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:34 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000252 · wk-form4_1696451642.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,716 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:28 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 46 | $65.93 | $3,032.78 |
DisclosureSEC source: 0001099219-23-000232 · wf-form4_169506892461388.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,006 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| August 07, 2023 Filed Aug 10, 2023 00:41 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 12,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-23-000097 · wk-form4_1691628085.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,406 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:18 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 803 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000195 · wf-form4_168746511725958.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,961 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:19 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 55 | $53.94 | $2,966.70 |
DisclosureSEC source: 0001099219-23-000177 · wf-form4_168694672926940.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,158 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 21:00 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 3,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-23-000069 · wf-form4_168064202974627.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,057 Underlying: Common Stock · 3,277 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 21:01 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 755 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000127 · wf-form4_168072846576072.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,103 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:34 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 48 | $59.07 | $2,835.36 |
DisclosureSEC source: 0001099219-23-000104 · wf-form4_167899888494187.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,348 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:00 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000082 · wf-form4_167780160360267.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,300 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:32 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 3,049 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-23-000015 · wf-form4_167286787961962.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,780 Underlying: Common Stock · 3,049 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on January 3, 2023 shall vest one year later on January 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on January 3, 2023 shall vest one year later on January 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:32 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000036 · wf-form4_167295431766042.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,269 F1 · kind: 1. MetLife, Inc's non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:23 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 39 | $72.84 | $2,840.76 |
DisclosureSEC source: 0001099219-22-000197 · wf-form4_167122577852510.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,749 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| October 03, 2022 Filed Oct 3, 2022 20:41 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 3,567 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-22-000139 · wf-form4_166482965762340.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,731 Underlying: Common Stock · 3,567 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on October 3, 2022 shall vest one year later on October 3, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on October 3, 2022 shall vest one year later on October 3, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:30 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000169 · wf-form4_166500178969194.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,710 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:24 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 42 | $66.41 | $2,789.22 |
DisclosureSEC source: 0001099219-22-000139 · wf-form4_166335985245241.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,111 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 22:55 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-22-000054 · wf-form4_165948093770470.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,006 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 22:19 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 4,538 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-22-000120 · wf-form4_165705957888948.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,164 Underlying: Common Stock · 4,538 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on July 1, 2022 shall vest one year later on July 1, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on July 1, 2022 shall vest one year later on July 1, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:13 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 600 | $62.53 | $37,518.00 |
DisclosureSEC source: 0000937834-22-000077 · wf-form4_165601517157631.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,069 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:27 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 45 | $61.86 | $2,783.70 |
DisclosureSEC source: 0000937834-22-000051 · wf-form4_165541125243308.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,469 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:03 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 4,626 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-22-000083 · wf-form4_164919618313142.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,626 Underlying: Common Stock · 4,626 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on April 1, 2022 shall vest one year later on April 1, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on April 1, 2022 shall vest one year later on April 1, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:11 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 532 | $70.50 | $37,506.00 |
DisclosureSEC source: 0001099219-22-000097 · wf-form4_164918945824769.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,424 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 20:35 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 41 | $64.69 | $2,652.29 |
DisclosureSEC source: 0001099219-22-000070 · wf-form4_164746293682194.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,892 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:30 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 3,368 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-22-000045 · wf-form4_164625658207740.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 3,368 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on February 28, 2022 shall vest one year later on February 28, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on February 28, 2022 shall vest one year later on February 28, 2023. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:40 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 594 | $63.23 | $37,558.62 |
DisclosureSEC source: 0000937834-22-000016 · wf-form4_164141881208768.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,851 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:34 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 43 | $60.80 | $2,614.40 |
DisclosureSEC source: 0001099219-21-000353 · wf-form4_163969044223464.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,257 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.